Artificial Intelligence in Medicine Market projected to reach $18,119 Million with top key players InSilico Medicine, Inc., Globavir Biosciences, Inc., GNS Healthcare, Flatiron Health, Benevolent AI, Atomwise, Verge Genomics, Cloud Pharmaceuticals, and Re

According to a new report published by Allied Market Research, titled, Artificial Intelligence in Medicine Market by Product Type, Technology, and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023," the market was valued at $719 million in 2017 and is estimated to reach $18,119 million at a CAGR of 49.6% from 2018 to 2025. North America was the highest contributor to the artificial intelligence in medicine market in 2017; however, Asia-Pacific is expected to witness the highest growth during the forecast period.

In the field of medicine, artificial intelligence (AI) can be used for research studies and applications that support decision-based medical tasks using data-intensive computer-based solutions. For every drug that is launched in the market, the pharmaceutical industry spends on an average $2.7 billion, which amortizes the losses incurred from the aborted pipelines. Almost 90% of all drug programs that reach clinical trial stages are aborted. Thus, many large pharma and academic research institutions are focusing on use of AI to increase efficiencies and design better drugs.

Get sample copy of this report :
https://www.alliedmarketresearch.com/request-sample/4749?utm_source=OPR

Key Findings of the Artificial Intelligence in Medicine Market:

• The personalized medicine segment is projected to grow at the highest rate among the application segment during the analysis period.

• North America dominated global artificial intelligence in medicine market in 2017 and is projected to continue its dominance in future.

• China is expected to grow at the highest rate in Asia-Pacific during the forecast period.

• Software is the largest contributor among the product type segments in 2017.

• The natural language processing segment generated the highest revenue and is expected to continue its dominance in future.

The major factors that drive the growth of the AI in medicine market include shortage of skilled healthcare professionals, the growth in importance of precision medicine, and increase in the processing power of AI systems that is estimated to help improve the efficiency of drug discovery and management of clinical trials. However, limited acceptance from healthcare professionals and limitations of AI decision-making limit the market growth. Conversely, the untapped market potential in developing regions such as India and China is anticipated to provide numerous opportunities for the market growth during the forecast period.

Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/4749?utm_source=OPR

Among the technology segments, the natural language processing segment accounted for the highest share in 2017 and is expected to dominate the market from 2017 to 2023. The deep learning segment is projected to grow at the highest CAGR during the forecast period, owing to increase in use of signal reduction, data mining, and image recognition, which are integral components of most AI protocols.

Top key players :

• InSilico Medicine Inc.
• Globavir Biosciences Inc.
• GNS Healthcare
• Flatiron Health
• Benevolent AI
• Atomwise
• Verge Genomics
• Cloud Pharmaceuticals
• Recursion Pharmaceuticals.

The key players operating in the global artificial intelligence in medicine market include Welltok, Inc., Intel Corporation, Nvidia Corporation, Google Inc., IBM Corporation, Microsoft Corporation, General Vision, Inc., Enlitic, Inc., BioXcel Corporation, and Berg Health.

Get Customized copy of this report
https://www.alliedmarketresearch.com/request-for-customization/4749?utm_source=OPR

Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Porter’s five forces analysis
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in processing power of AI systems leading to enhanced AI capabilities
3.4.1.2. Dearth of skilled healthcare professionals
3.4.1.3. Growing importance of precision medicine

3.4.2. Restraints

3.4.2.1. Limitations of AI decision-making
3.4.2.2. Limited acceptance from healthcare professionals

3.4.3. Opportunities

3.4.3.1. Untapped market in developing regions

LIST OF TABLES

TABLE 01. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 02. ARTIFICIAL INTELLIGENCE HARDWARE IN MEDICINE MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 03. ARTIFICIAL INTELLIGENCE SOFTWARE IN MEDICINE MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 04. ARTIFICIAL INTELLIGENCE SERVICES IN MEDICINE MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 05. GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)
TABLE 06. ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR DEEP LEARNING, BY REGION, 2017–2025 ($MILLION)
TABLE 07. ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR QUERYING METHOD, BY REGION, 2017–2025 ($MILLION)
TABLE 08. ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY REGION, 2017–2025 ($MILLION)
TABLE 09. ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR CONTEXT AWARE PROCESSING, BY REGION, 2017–2025 ($MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 11. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR DRUG DISCOVERY, BY REGION, 2017–2025 ($MILLION)
TABLE 12. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR CLINICAL RESEARCH TRIAL, BY REGION, 2017–2025 ($MILLION)
TABLE 13. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2017–2025 ($MILLION)
TABLE 14. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR OTHER MEDICINE APPLICATIONS, BY REGION, 2017–2025 ($MILLION)
TABLE 15. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 16. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 17. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)
TABLE 18. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 19. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 20. U.S. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 21. U.S. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)
TABLE 22. U.S. ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 23. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 24. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)
TABLE 25. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 26. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 27. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)
TABLE 28. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 29. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 30. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)

Get Access to Full summary of this report at :
https://www.alliedmarketresearch.com/artificial-intelligence-in-medicine-market
?utm_source=OPR

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David c
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.